Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST) CAMBRIDGE, Mass. / Aug 11, 2025 / Business Wire / Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company will present new data from its hypertension and transthyretin amyloidosis (ATTR) programs at the upcoming European Society of Cardiology (ESC) Congress 2025, taking place in... Read More